Latest News and Press Releases

LONDON and NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of...

LONDON and NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of...

Dr. Mantelli, former Chief Medical Officer at Dompé, spearheaded the successful clinical development program and FDA approval of Oxervate®, a blockbuster orphan therapy in corneal diseaseDr. Mantelli...

Accomplished industry leader Robert J. Dempsey brings extensive commercialization and ophthalmic expertise Gary S. Jacob, Ph.D., will transition to Chief Development Officer and continue to serve on...

First Responders Children's Foundation announces retired NYPD Chief Theresa Tobin as Chief National Public Safety Liaison.

NEW YORK, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...

ITHACA, NY, June 14, 2023 (GLOBE NEWSWIRE) -- SimpliFed, the telehealth platform dedicated to virtual breastfeeding and baby feeding support, no matter how you feed your baby, announced today that...

NEW YORK, June 13, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via...

Fort Myers, Fla., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Florida Cancer Specialists & Research Institute (FCS) pleased to announce that Josh Eaves has been appointed as Chief Development &...

Kelowna, Jan. 17, 2022 (GLOBE NEWSWIRE) -- Canadian Council for Aboriginal Business (CCAB) is pleased to announce business leader, Robert Louie, as the 2022 recipient of the annual Aboriginal...